Associations

International Association for the Study of Lung Cancer

About the International Association for the Study of Lung Cancer

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists in over 100 countries. IASLC members work to enhance the understanding of lung cancer among scientists, members of the medical community and the public. IASLC publishes the Journal of Thoracic Oncology, a valuable resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.

 
sitc log color png

Project Partner: The Lung Cancer Registry sponsored by the Bonnie J. Addario Lung Cancer Foundation (ALCF), the American Lung Association's LUNG FORCE and the International Association for the Study of Lung Cancer (IASLC), is joining Adam Dicker, M.D., Ph.D. at Sidney Kimmel Cancer Center, Thomas Jefferson University and Heather Jim, Ph.D. at H. Lee Moffitt Cancer Center and Research Institute, Inc., in a study to learn about side effects of immunotherapy from patients with non-small cell lung cancer (NSCLC) who have undergone therapy with immune checkpoint inhibitors. We wish to thank The Society for Immunotherapy of Cancer (SITC) for joining the collaboration as a “Project Partner” to maximize awareness of the registry and this research study to both researchers and patients.

About the Society for Immunotherapy of Cancer

The Society for Immunotherapy of Cancer (SITC) is the world's leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through in-person and online educational programs that provide state-of-the-art continuing education for the entire cancer care team; open access peer-reviewed guidelines, articles and other resources; interactive, audience-specific online communities; and by fostering collaboration between expert researchers and oncology practitioners, SITC aims to one day make the word "cure" a reality for cancer patients everywhere.

 

The Lung Cancer Registry is sponsored by: